Targeting RAS for anticancer therapy.

被引：0

作者：

Campbell, Sharon ^{[1
]}

Carey, Leiah ^{[1
]}

Prakash, Ajit ^{[1
]}

Clark, Geoff ^{[2
]}

Scarry, Sarah ^{[1
]}

Aube, Jeff ^{[1
]}

机构：

[1] Univ N Carolina, Chapel Hill, NC 27515 USA

[2] Univ Louisville, Louisville, KY 40292 USA

来源：

MOLECULAR CANCER RESEARCH | 2020年 / 18卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

IA04

引用

页码：18 / 18

页数：1

共 50 条

[31] Anticancer Drug Delivery for Tumor Targeting and Therapy [J].

Kim, Yu Jin ;

Park, Il-Kyu ;

Kim, Jin Soo ;

Hwang, Joon ;

Chung, Eui-Sik ;

Huh, Kang Moo ;

Lee, Yong-kyu .

2009 4TH IEEE INTERNATIONAL CONFERENCE ON NANO/MICRO ENGINEERED AND MOLECULAR SYSTEMS, VOLS 1 AND 2, 2009, :919-+

[32] Targeting SOX2 in anticancer therapy [J].

Hueser, Laura ;

Novak, Daniel ;

Umansky, Viktor ;

Altevogt, Peter ;

Utikal, Jochen .

EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (12) :983-991

[33] Targeting apoptosis signaling pathways for anticancer therapy [J].

Fulda, Simone .

FRONTIERS IN ONCOLOGY, 2011, 1

[34] Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy [J].

Abellan-Pose, Raquel ;

Csaba, Noemi ;

Jose Alonso, Maria .

CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (09) :1194-1209

[35] Targeting the Mevalonate Pathway for Improved Anticancer Therapy [J].

Fritz, G. .

CURRENT CANCER DRUG TARGETS, 2009, 9 (05) :626-638

[36] Anticancer Therapy Targeting Telomeres and TelomeraseCurrent Status [J].

E. Kenneth Parkinson ;

Fay Minty .

BioDrugs, 2007, 21 :375-385

[37] Targeting necroptosis in anticancer therapy: mechanisms and modulators [J].

Wu, Ying ;

Dong, Guoqiang ;

Sheng, Chunquan .

ACTA PHARMACEUTICA SINICA B, 2020, 10 (09) :1601-1618

[38] Advances in targeting RNA modifications for anticancer therapy [J].

Pomaville, Monica M. ;

He, Chuan .

TRENDS IN CANCER, 2023, 9 (07) :528-542

[39] Cyclic 3',5'-nucleotide phosphodiesterases: Potential targets for anticancer therapy. [J].

Eisenbrand, G ;

Marko, D ;

Pahlke, G .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 :U479-U479

[40] An insoluble radioiodinated quinazolinone derivative for enzyme-mediated anticancer therapy. [J].

Wang, K ;

Wang, P ;

Chen, K ;

Adelstein, SJ ;

Kassis, AI .

JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) :306P-306P

← 1 2 3 4 5 →